BIRC5 and cancer: The analyses of Survivin expression in cancer tissues of the parallel experimental groups showed that the combined therapeutic intervention strategy with oncolytic adenovirus AdSurp-Hsp70 injection and CIK cell infusion had a more significant effect on tumor xenografts with high expression of Survivin.